WCG IPO Presentation Deck
30
WCG is Not a CRO - We Make CROS More Cost Effective & Efficient
What Makes WCG Different than a CRO?
CROS are outsourcing generalists that run
clinical trials from end-to-end on behalf of
biopharma sponsors - WCG is a specialist
that focuses only on 4 pain points of the trial
process.
CROS conduct clinical trial monitoring as a
matter of regulatory obligation - WCG does
not do clinical trial monitoring.
CROS cannot be an IRB because they
monitor clinical trials. This would be a
conflict of interest.
CROS are major clients of WCG -WCG
supports CROS with our proprietary
technology and specialty clinical solutions
Outsourced Clinical Services (2020)
Clinical Solution
Clinical Monitoring
Investigator Payments
Laboratory
Data Management
Project Management
Patient & Site Recruitment
Technology
Biostatistics
Imaging
Medical Writing
Regulatory
Quality Assurance
Other
IRB / Ethical Review
Total
CRO Revenue ($B)
$ 7.4
$ 5.1
$
4.2
$
4.0
$ 3.4
$ 3.4
$ 3.1
$
2.5
$ 1.5
$ 1.2
$
1.1
$ 0.9
$ 0.7
N/A
$ 38.4
CRO
Conflicted
WCG Revenue ($B)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
WCG Clinical
$ 0.224 Trial Solutions
Segment
$ 0.239
DN L
$0.463
wcg
Source: Statista (June 2021), Industry Standard Research (May 2019), and management estimates.
Note: Outsourced Clinical Services includes CSO, CRO, and other outsourced services.
WCG Ethical
Review
SegmentView entire presentation